On 8/13/24, Sanara Medtech Inc (NASDAQ: SMTI) stock enjoyed a major increase of 15.1%, closing at $32.04. Moreover, this advance was accompanied by unusually high trading volume at 158% of normal. The stock has risen 19.0% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, SMTI is expected to continue to be a modest Value Eraser.
Sanara Medtech has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Sanara Medtech has a poor Power Rating of 18 and a very low Appreciation Score of 6, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment